- Home
- Publications
- Publication Search
- Publication Details
Title
Advances in Treatment of Diffuse Midline Gliomas
Authors
Keywords
-
Journal
Current Neurology and Neuroscience Reports
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-03
DOI
10.1007/s11910-023-01317-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pediatric diffuse midline glioma H3K27- altered: A complex clinical and biological landscape behind a neatly defined tumor type
- (2023) Stefano Gabriele Vallero et al. Frontiers in Oncology
- GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas
- (2022) Robbie G. Majzner et al. NATURE
- Nimotuzumab as Additional Therapy for GLIOMA in Pediatric and Adolescent: A Systematic Review
- (2022) Muhammad A Parenrengi et al. Cancer Control
- The intrinsic and microenvironmental features of diffuse midline glioma: Implications for the development of effective immunotherapeutic treatment strategies
- (2022) Mika L Persson et al. NEURO-ONCOLOGY
- MRI and Molecular Characterization of Pediatric High-Grade Midline Thalamic Gliomas: The HERBY Phase II Trial
- (2022) Daniel Rodriguez et al. RADIOLOGY
- Pediatric Diffuse Midline Gliomas: An Unfinished Puzzle
- (2022) Valentina Di Ruscio et al. Diagnostics
- Mutations within FGFR1 are associated with superior outcome in a series of 83 diffuse midline gliomas with H3F3A K27M mutations
- (2021) Ulrich Schüller et al. ACTA NEUROPATHOLOGICA
- Cell cycle control in cancer
- (2021) Helen K. Matthews et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Characteristics of patients ≥10 years of age with diffuse intrinsic pontine glioma: a report from the International DIPG/DMG Registry
- (2021) Craig Erker et al. NEURO-ONCOLOGY
- Phase I/II trial of vorinostat and radiation and maintenance vorinostat in children with diffuse intrinsic pontine glioma: A Children’s Oncology Group report
- (2021) Jack M Su et al. NEURO-ONCOLOGY
- Repurposing vandetanib plus everolimus for the treatment of ACVR1-mutant diffuse intrinsic pontine glioma
- (2021) Diana M Carvalho et al. Cancer Discovery
- Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutant
- (2021) Emmanuel de Billy et al. NEURO-ONCOLOGY
- Emerging Advances in Combinatorial Treatments of Epigenetically Altered Pediatric High-Grade H3K27M Gliomas
- (2021) Katarzyna B. Leszczynska et al. Frontiers in Genetics
- Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibition
- (2020) Gourish Mondal et al. ACTA NEUROPATHOLOGICA
- Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas
- (2020) Scott Ryall et al. CANCER CELL
- Immune checkpoint inhibition for pediatric patients with recurrent/refractory CNS tumors: a single institution experience
- (2020) Chantel Cacciotti et al. JOURNAL OF NEURO-ONCOLOGY
- A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG)
- (2020) Mariko DeWire et al. JOURNAL OF NEURO-ONCOLOGY
- A Phase I/II Trial of Reirradiation for Diffuse Intrinsic Pontine Glioma
- (2019) Mark J. Amsbaugh et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
- (2019) Timothy F. Cloughesy et al. NATURE MEDICINE
- Nimotuzumab and radiotherapy for treatment of newly diagnosed diffuse intrinsic pontine glioma (DIPG): a phase III clinical study
- (2019) G. Fleischhack et al. JOURNAL OF NEURO-ONCOLOGY
- The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models
- (2019) Naiara Martínez-Vélez et al. Nature Communications
- PDCT-01. BIOLOGICAL MEDICINE FOR DIFFUSE INTRINSIC PONTINE GLIOMAS ERADICATION (BIOMEDE): RESULTS OF THE THREE-ARM BIOMARKER-DRIVEN RANDOMIZED TRIAL IN THE FIRST 230 PATIENTS FROM EUROPE AND AUSTRALIA
- (2019) Jacques Grill et al. NEURO-ONCOLOGY
- Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas
- (2018) Christopher W. Mount et al. NATURE MEDICINE
- IMMU-09. OUTCOME OF PATIENTS WITH RECURRENT DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) TREATED WITH PEMBROLIZUMAB (ANTI-PD-1): A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY (PBTC045)
- (2018) Eugene Hwang et al. NEURO-ONCOLOGY
- Reirradiation in patients with diffuse intrinsic pontine gliomas: The Canadian experience
- (2018) Alvaro Lassaletta et al. PEDIATRIC BLOOD & CANCER
- Immune Response Generated With the Administration of Autologous Dendritic Cells Pulsed With an Allogenic Tumoral Cell-Lines Lysate in Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma
- (2018) Daniel Benitez-Ribas et al. Frontiers in Oncology
- Abstract 958: Anti-GD2 chimeric antigen receptor T cells as a potent immunotherapy regimen in xenograft models of histone 3 K27M mutant diffuse midline glioma
- (2018) Christopher W. Mount et al. CANCER RESEARCH
- Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: a single-institution experience
- (2018) Cassie Kline et al. JOURNAL OF NEURO-ONCOLOGY
- Nimotuzumab-containing regimen for pediatric diffuse intrinsic pontine gliomas: a retrospective multicenter study and review of the literature
- (2018) Rejin Kebudi et al. CHILDS NERVOUS SYSTEM
- Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group
- (2017) Geert O. Janssens et al. EUROPEAN JOURNAL OF CANCER
- A phase I/II study of gemcitabine during radiotherapy in children with newly diagnosed diffuse intrinsic pontine glioma
- (2017) Sophie E. M. Veldhuijzen van Zanten et al. JOURNAL OF NEURO-ONCOLOGY
- Concomitant Use of Panobinostat and Reirradiation in Progressive DIPG
- (2017) Zhihong J. Wang et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location
- (2017) Michael Karremann et al. NEURO-ONCOLOGY
- Diffuse intrinsic pontine gliomas—current management and new biologic insights. Is there a glimmer of hope?
- (2017) Kenneth J. Cohen et al. NEURO-ONCOLOGY
- K27M mutation inH3F3Ain ganglioglioma grade I with spontaneous malignant transformation extends the histopathological spectrum of the histone H3 oncogenic pathway
- (2017) N. Joyon et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Poly-(ADP-ribose)-polymerase inhibitors as radiosensitizers: a systematic review of pre-clinical and clinical human studies
- (2017) Paul Lesueur et al. Oncotarget
- K27M-mutant histone-3 as a novel target for glioma immunotherapy
- (2017) Katharina Ochs et al. OncoImmunology
- Pre-Clinical Study of Panobinostat in Xenograft and Genetically Engineered Murine Diffuse Intrinsic Pontine Glioma Models
- (2017) Tammy Hennika et al. PLoS One
- A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors
- (2017) Oren J. Becher et al. PLoS One
- Advances in the biology and treatment of pediatric central nervous system tumors
- (2016) Nicholas A. Vitanza et al. CURRENT OPINION IN PEDIATRICS
- Pembrolizumab: first experience with recurrent primary central nervous system (CNS) tumors
- (2016) Deborah T. Blumenthal et al. JOURNAL OF NEURO-ONCOLOGY
- A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors
- (2016) Oren J. Becher et al. PEDIATRIC BLOOD & CANCER
- Diffuse Midline Gliomas with Histone H3-K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations
- (2015) David A. Solomon et al. BRAIN PATHOLOGY
- Poly-ADP-Ribose Polymerase as a Therapeutic Target in Pediatric Diffuse Intrinsic Pontine Glioma and Pediatric High-Grade Astrocytoma
- (2015) Y. Chornenkyy et al. MOLECULAR CANCER THERAPEUTICS
- Evidence forBRAFV600E andH3F3AK27M double mutations in paediatric glial and glioneuronal tumours
- (2015) Anh Tuan Nguyen et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Pathology, Molecular Genetics, and Epigenetics of Diffuse Intrinsic Pontine Glioma
- (2015) Pawel Buczkowicz et al. Frontiers in Oncology
- DIPG in Children – What Can We Learn from the Past?
- (2015) Magimairajan Issai Vanan et al. Frontiers in Oncology
- PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependymoma to radiation
- (2015) Dannis Gilbert Van Vuurden et al. Oncotarget
- Subventricular spread of diffuse intrinsic pontine glioma
- (2014) Viola Caretti et al. ACTA NEUROPATHOLOGICA
- Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications
- (2014) Pawel Buczkowicz et al. ACTA NEUROPATHOLOGICA
- Preclinical evaluation of dasatinib alone and in combination with cabozantinib for the treatment of diffuse intrinsic pontine glioma
- (2014) Nathalène Truffaux et al. NEURO-ONCOLOGY
- Phase I Trial, Pharmacokinetics, and Pharmacodynamics of Vandetanib and Dasatinib in Children with Newly Diagnosed Diffuse Intrinsic Pontine Glioma
- (2013) A. Broniscer et al. CLINICAL CANCER RESEARCH
- Mesenchymal Transition and PDGFRA Amplification/Mutation Are Key Distinct Oncogenic Events in Pediatric Diffuse Intrinsic Pontine Gliomas
- (2012) Stephanie Puget et al. PLoS One
- Palliative Reirradiation for Progressive Diffuse Intrinsic Pontine Glioma
- (2011) Hiral P. Fontanilla et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Diffuse intrinsic pontine gliomas: A systematic update on clinical trials and biology
- (2011) M.H.A. Jansen et al. CANCER TREATMENT REVIEWS
- Genome-Wide Analyses Identify Recurrent Amplifications of Receptor Tyrosine Kinases and Cell-Cycle Regulatory Genes in Diffuse Intrinsic Pontine Glioma
- (2011) Barbara S. Paugh et al. JOURNAL OF CLINICAL ONCOLOGY
- Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group
- (2011) K. J. Cohen et al. NEURO-ONCOLOGY
- A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas
- (2010) J. Russell Geyer et al. EUROPEAN JOURNAL OF CANCER
- Phase I Study of Vandetanib During and After Radiotherapy in Children With Diffuse Intrinsic Pontine Glioma
- (2010) Alberto Broniscer et al. JOURNAL OF CLINICAL ONCOLOGY
- Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors
- (2010) B. Geoerger et al. NEURO-ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started